Related Experiment Video
Updated: Sep 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Systematic review of the effects of pertussis vaccines in children
Tom Jefferson1, Melanie Rudin, Carlo DiPietrantonj
1Health Reviews Ltd., Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy. toj1@aol.com
Insights
Both whole-cell and acellular pertussis vaccines are effective. Acellular vaccines with three or more components offer higher efficacy and a better safety profile than whole-cell vaccines.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Pertussis, also known as whooping cough, is a highly contagious respiratory infection.
- Vaccination is the primary strategy for preventing pertussis.
- Whole-cell and acellular pertussis vaccines are available, often administered within diphtheria, tetanus, and pertussis (DTP) combination vaccines.
Purpose of the Study:
- To evaluate the effectiveness and safety of whole-cell and acellular pertussis vaccines.
- To compare different types of pertussis vaccines, including those with varying antigenic components.
- To assess adverse events associated with pertussis vaccination in children.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials (RCTs) and cohort studies.
- Searched major scientific databases (Cochrane Library, MEDLINE, EMBASE, etc.) up to December 2001.
- Included studies comparing pertussis vaccines against placebo, DT vaccine, or each other.
Main Results:
- All tested whole-cell and acellular pertussis vaccines demonstrated significant efficacy compared to placebo.
- Whole-cell DTP vaccines showed variable efficacy (37-92%).
- Acellular vaccines with three or more components had higher efficacy (80-84%) than those with one or two components (67-70%).
- Whole-cell vaccines were linked to increased local reactions, fever, and prolonged crying.
- Acellular vaccines had a similar adverse event profile to placebo and were safer than whole-cell vaccines.
Conclusions:
- All evaluated pertussis vaccines are efficacious in preventing pertussis.
- Acellular pertussis vaccines containing three or more antigenic components exhibit superior efficacy compared to those with fewer components.
- Acellular pertussis vaccines possess a more favorable safety profile than whole-cell pertussis vaccines.
Objective:
To assess the efficacy and safety of whole-cell and acellular pertussis vaccines administered to children singly or within diphtheria, tetanus and pertussis (DTP) vaccines.
Data Sources:
We searched the Cochrane Library, MEDLINE, EMBASE, Biological Abstracts and Science Citation Index to December 2001. Specialised websites and bibliographies of retrieved articles and reviews were assessed. Vaccine manufacturers and investigators were contacted for additional data.
Review Methods:
We included randomised and cohort studies comparing efficacy and/or safety of pertussis vaccines with placebo, DT, no intervention or each other.
Results:
We included 52 studies (49 randomised controlled trials (RCTs), 3 cohort studies). All tested whole-cell and acellular vaccines were significantly more effective than placebo against pertussis. Absolute efficacy of whole-cell DTP varied from 37 to 92%. One- and two-component acellular vaccines had lower absolute efficacy (67-70%), than vaccines with >/=3 components (80-84%). Whole-cell vaccines were associated with significantly higher incidences of swelling and induration (odds ratio (OR) 11.67, 95% confidence interval (CI) 8.83-15.44), fever (OR for fever >39 degrees C 3.36, 95% CI 2.06-5.49) and crying for >2h (OR 4.72, 95% CI 2.94-7.59) than placebo or DT. Differences in incidence of hypotonic hyporesponsive episodes (HHE) and convulsions were not statistically significant. Acellular pertussis vaccines did not cause a higher incidence of local signs, fever, convulsions, HHE or prolonged crying than placebo or DT.
Conclusion:
All tested pertussis vaccines were efficacious. Whole-cell vaccines show variable efficacy, making interpretation of direct comparisons unreliable. Acellular vaccines with >/=3 antigenic components showed higher efficacy than one- and two-component vaccines. The adverse event profile of acellular vaccines was similar to that of placebo and considerably better than that of whole-cell vaccines.
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Poliomyelitis
Vaccines
Chickenpox

